Gene · 9113
NIH grants1,633
NIH grants whose papers are about the gene, through NIH's grant-paper links.
141 to 160 of 1,633
Download this page as JSON| Grant | Title | LATS1 papers | Newest fiscal year |
|---|---|---|---|
| P50CA121974 | Yale SPORE in Skin Cancer | 1 | 2025 |
| P50CA136393 | Use of microfluidic tumor cultures to enable clinical trials of therapies for ovarian cancer | 1 | 2025 |
| P50CA180995 | SPORE in Prostate Cancer | 1 | 2025 |
| P50CA217694 | SPORE in Soft Tissue Sarcoma | 1 | 2025 |
| P50CA247749 | MSK SPORE in Genomic Instability in Breast Cancer | 1 | 2025 |
| P51OD011104 | Tulane National Primate Research Center | 1 | 2025 |
| P60AA009803 | LSUHSC-NO Comprehensive Alcohol-HIV/AIDS Research Center (CARC) | 1 | 2025 |
| R01AA010154 | TNF alpha and Recovery from Alcoholic Liver Injury | 1 | 2025 |
| R01AG050986 | Higher Order Chromatin and Genetic Risk for Alzheimer's Disease | 1 | 2025 |
| R01AG076051 | Mechanism of white matter pathology in Alzheimer's disease | 1 | 2025 |
| R01AI040127 | Signal transduction and gene induction in lymphocytes | 1 | 2025 |
| R01AI060025 | From Drosophila Immunity to Anti-Inflammatories | 1 | 2025 |
| R01AI130025 | Role of the gender biased transcription factor VGLL3 in promoting autoimmune responses in SLE | 1 | 2025 |
| R01AI135201 | The role of HLA and its coreceptors in endothelial cell activation and leukocyte recruitment in antibody-mediated transplant rejection | 1 | 2025 |
| R01AI161363 | Mechanism-based Targeting of the RNA Processing Machinery of SARS-CoV-2 | 1 | 2025 |
| R01AI163216 | Developing three-dimensional antisense oligonucleotide drugs against COVID-19 | 1 | 2025 |
| R01AI179926 | Development of 2C inhibitors as broad-spectrum enterovirus antivirals | 1 | 2025 |
| R01AR071384 | Characterization of interferon kappa as a novel target in cutaneous lupus | 1 | 2025 |
| R01AR077664 | Mechanisms of cAMP-dependent regulation of melanosome pH | 1 | 2025 |
| R01AR081640 | Hippo signaling as a critical regulator of lupus keratinocyte dysfunction | 1 | 2025 |
Source NIH's project filesgene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/9113/grants?page=8